Tony Antoniou, Graham Smith, Desheng Su, Janet M Raboud, Derek Lee, Colin Kovacs, Jason Brunetta, David Fletcher, Fred Crouzat, Mona Loutfy
{"title":"Immunologic effectiveness of maraviroc- and raltegravir-containing regimens (R+M+) versus raltegravir-based regimens that do not include maraviroc (R+M-).","authors":"Tony Antoniou, Graham Smith, Desheng Su, Janet M Raboud, Derek Lee, Colin Kovacs, Jason Brunetta, David Fletcher, Fred Crouzat, Mona Loutfy","doi":"10.1177/1545109711424967","DOIUrl":"https://doi.org/10.1177/1545109711424967","url":null,"abstract":"<p><strong>Objective: </strong>To compare the immunologic effectiveness of raltegravir-maraviroc (R+M+)-based regimens with raltegravir-based regimens that do not include maraviroc (R+M-) in treatment-experienced patients in clinical practice.</p><p><strong>Methods: </strong>We conducted a retrospective study of treatment-experienced HIV-infected adults receiving either R+M+- or R+M--based therapy. Longitudinal CD4 counts were analyzed using a linear mixed model.</p><p><strong>Results: </strong>One hundred and fifty-six patients were included in the analysis, of whom 32 were receiving R+M+ and 124 R+M-. Mean baseline CD4 counts in patients on R+M+ and R+M- were 463.8 and 442.3 cells/mm(3), respectively (P = .67). In multivariable mixed models, a baseline viral load ≥50 copies/mL was significantly associated with CD4 change during follow-up (P < .0001). No difference between R+M+ and R+M- was observed during follow-up (P = .81).</p><p><strong>Conclusion: </strong>CD4 cell recovery was similar among patients receiving either R+M+- or R+M--based therapy during a 24-month period of follow-up.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 3","pages":"192-7"},"PeriodicalIF":0.0,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109711424967","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30387745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rotimi S Owolabi, Peter Alabi, Samuel Ajayi, Olusoji Daniel, Adeniyi Ogundiran, Tanimola M Akande, And Tunde Onafowokan
{"title":"Knowledge and practice of post-exposure prophylaxis (PEP) against HIV infection among health care providers in a tertiary hospital in Nigeria.","authors":"Rotimi S Owolabi, Peter Alabi, Samuel Ajayi, Olusoji Daniel, Adeniyi Ogundiran, Tanimola M Akande, And Tunde Onafowokan","doi":"10.1177/1545109711401409","DOIUrl":"https://doi.org/10.1177/1545109711401409","url":null,"abstract":"<p><strong>Objective: </strong>To assess the knowledge and practice of post exposure prophylaxis (PEP) against HIV infection among health care providers in University of Abuja Teaching Hospital (UATH).</p><p><strong>Methods: </strong>A cross-sectional survey conducted on 230 health care providers in UATH.</p><p><strong>Results: </strong>Majority (97.0%) of the respondents have heard about PEP, but only a few (30.9%) of them could correctly identify the drugs used and duration of PEP. A third of respondents have had one form of accidental exposure or the other. HIV test was carried out in about two-thirds (64.8%) of the source patients. Thirteen (28.3%) of the source patients were HIV-positive. Of the 13 respondents that were exposed to HIV-positive patients, only 3 (23.1%) received PEP, and these three completed PEP, while majority, 10/13 (76.9%) did not receive PEP in spite of their exposure to HIV-positive sources.</p><p><strong>Conclusion: </strong>The study shows that the knowledge and practice of PEP among health care providers are very poor.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 3","pages":"179-83"},"PeriodicalIF":0.0,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109711401409","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29831640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Samuel Anu Olowookere, Akinola Ayoola Fatiregun, Modupe Martha-Alice Ladipo, Yetunde Adebisi Akenova
{"title":"Reducing waiting time at a Nigerian HIV treatment clinic: opinions from and the satisfaction of people living with HIV/AIDS.","authors":"Samuel Anu Olowookere, Akinola Ayoola Fatiregun, Modupe Martha-Alice Ladipo, Yetunde Adebisi Akenova","doi":"10.1177/1545109711402214","DOIUrl":"https://doi.org/10.1177/1545109711402214","url":null,"abstract":"<p><p>We assessed the waiting time and perceived satisfaction with care among people living with HIV/AIDS (PLHIV) at an antiretroviral clinic in Nigeria. A structured questionnaire was administered during interviews. Four hundred patients completed the questionnaire. The mean age of the respondents was 36.4 years (SD 9.7 years), and 61% of them were females. A majority, 72.9%, reported that the time elapsed between entry into the clinic and access to medical care services (waiting time) was more than an hour. However, a majority (77%) expressed satisfaction with the medical care they received. Although the majority of PLHIV were satisfied with their medical care, more needs to be done to reduce patient waiting time before access to medical services.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 3","pages":"188-91"},"PeriodicalIF":0.0,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109711402214","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29841326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jean B Nachega, Chelsea Morroni, José M Zuniga, Renslow Sherer, Chris Beyrer, Suniti Solomon, Mauro Schechter, Jürgen Rockstroh
{"title":"HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults.","authors":"Jean B Nachega, Chelsea Morroni, José M Zuniga, Renslow Sherer, Chris Beyrer, Suniti Solomon, Mauro Schechter, Jürgen Rockstroh","doi":"10.1177/1545109712436723","DOIUrl":"https://doi.org/10.1177/1545109712436723","url":null,"abstract":"<p><strong>Background: </strong>Little is known globally about the perspectives of people living with HIV/AIDS (PLWHA) on perceived HIV-related stigma and its consequences.</p><p><strong>Methods: </strong>Cross-sectional study (January-March 2010) of perceived HIV-related stigma among PLWHA (N = 2035) using a standardized questionnaire.</p><p><strong>Findings: </strong>Thirty-seven percent of respondents reported loneliness as a result of their HIV status. Depression was reported by 27%. While 96% reported disclosing their HIV status to at least 1 person, 17% of patients who reported being in a long-term sexual relationship had not disclosed their status to their partner. Variables associated with perceived stigma were living in Asia-Pacific versus other regions (odds ratio [OR]: 2.77; 95% confidence interval [CI] 1.96-3.92); having experienced body/face changes; reported depression (OR: 1.25; 95% CI 1.11-1.38); and nondisclosure of HIV status (OR: 1.75; 95% CI 1.28-2.41).</p><p><strong>Conclusion: </strong>Thirty years into the HIV pandemic, perceived HIV stigma, isolation, and discrimination persist and are associated with loneliness and depression among PLWHA.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 3","pages":"172-8"},"PeriodicalIF":0.0,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109712436723","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30514517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G Manoharan, Shoba Dharmarajan, P K Ramalingam, Siju Mathew, Jacob C Varghese
{"title":"Mobile phone communication and health system strengthening: a pilot study of telephonic warmline consultation in HIV care and support in South India.","authors":"G Manoharan, Shoba Dharmarajan, P K Ramalingam, Siju Mathew, Jacob C Varghese","doi":"10.1177/1545109711428010","DOIUrl":"https://doi.org/10.1177/1545109711428010","url":null,"abstract":"<p><strong>Introduction: </strong>I-TECH India established a warmline pilot in the year 2008 to provide mobile-based technical support on clinical management to doctors caring for HIV patients in antiretroviral therapy (ART) centers.</p><p><strong>Methods: </strong>Warmline was piloted from May to August 2008. Standardized call records were analyzed. Statistical analyses were performed using SPSS.</p><p><strong>Results: </strong>The service was used by 38 doctors. The study demonstrated the frequency of calls and the nature of questions raised by them. Of the calls, 139 were new calls (90.3%) and 15 were follow-up calls. The average number of calls per day was 2.6 (SD 1.6). Of the total number, 81% of the calls were from high-volume centers. Most of the calls were related to ARV toxicities, ART initiation, and the management of opportunistic infections (OI).</p><p><strong>Conclusion: </strong>The South Indian warmline pilot demonstrated a potential model of ongoing technical assistance to ART doctors in times of need. AIDS-control organizations may consider expanding this model of expert distance-mentoring clinical support as a resource in India and other countries.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 3","pages":"184-7"},"PeriodicalIF":0.0,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109711428010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30478930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Juliana Ribeiro Romeiro, Jorge Andrade Pinto, Maria Luiza Silva, Silvana Maria Eloi-Santos
{"title":"Further evidence that the expression of CD38 and HLA-DR(+) in CD8(+) lymphocytes does not correlate to disease progression in HIV-1 vertically infected children.","authors":"Juliana Ribeiro Romeiro, Jorge Andrade Pinto, Maria Luiza Silva, Silvana Maria Eloi-Santos","doi":"10.1177/1545109711421642","DOIUrl":"https://doi.org/10.1177/1545109711421642","url":null,"abstract":"<p><strong>Background: </strong>In adults, an increase in CD8(+)CD38(+) T cell levels is a strong indicator of disease progression in HIV infection. However, in children, data are conflicting. Slow-progressing children (SPC) provide an exceptional resource for the investigation and clarification of the immunological and virological mechanisms of natural control of HIV infection and can be used to investigate prognostic indicators of disease progression.</p><p><strong>Objectives: </strong>To investigate the immune activation status and T regulatory (Treg) cell levels in SPC.</p><p><strong>Study design: </strong>A cross-sectional study was carried out on 28 children 8 years old and older who were vertically infected with HIV. The children were stratified into 3 groups according to their clinical outcome: SPC (anti-retroviral-therapy-naïve; ≥8 years-old; CD4 ≥20%; viral load <25,000 copies), IF/VF (anti-retroviral-therapy but with no therapeutic response), and IS/VS (anti-retroviral therapy with good therapeutic response). Uninfected children (NI) were assessed as healthy control group.</p><p><strong>Results: </strong>A higher percentage of activated CD8(+) T cells were found in all HIV infected children, regardless of the evolution of disease. The activation of CD8(+) T cells was not associated with either viral load or the percentage of CD4(+) T cells. In addition, Treg cell levels did not show any correlation with the clinical outcome or the activation status of CD8(+) T cells.</p><p><strong>Conclusions: </strong>HIV-1-infected children presented an increased percentage of activated CD8(+) T cells and an unaltered percentage of Treg cells, regardless of their clinical evolution. Thus, these immunological parameters should not be used for prognostic evaluation.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 3","pages":"164-8"},"PeriodicalIF":0.0,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109711421642","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30187861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preferences for rapid point-of-care HIV testing in primary care.","authors":"Michael Schwandt, Eileen Nicolle, Sheila Dunn","doi":"10.1177/1545109711427605","DOIUrl":"https://doi.org/10.1177/1545109711427605","url":null,"abstract":"<p><p>Although the identification of individuals infected with HIV is an important element of treatment and prevention programs, many people living with HIV are unaware of their status. Thus, individuals are unable to benefit from treatment, and preventable HIV transmission continues to occur. Rapid point-of-care testing for HIV has been found to be preferred by patients in some contexts. However, few studies have examined preferences in primary care populations. This study investigates HIV testing preferences within an urban primary care clinic. Employing a cross-sectional design, data were collected on demographic characteristics, HIV risk factors, and testing history and preferences of participants. A total of 81% of participants stated that they would prefer rapid testing to standard testing, a finding that is consistent across demographic variables and risk factors examined. Increased availability of this modality may decrease barriers to HIV testing, with positive implications both for clinical management of HIV infection and prevention of HIV transmission.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 3","pages":"157-63"},"PeriodicalIF":0.0,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109711427605","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30387784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Roy Nasnas, Marc Y Matta, Gilbert El Helou, Nathalie Rizk, Dolla Karam Sarkis, Ronald Moussa
{"title":"Brain abscesses in HIV-positive patients due to Pneumocystis jiroveci.","authors":"Roy Nasnas, Marc Y Matta, Gilbert El Helou, Nathalie Rizk, Dolla Karam Sarkis, Ronald Moussa","doi":"10.1177/1545109712439625","DOIUrl":"https://doi.org/10.1177/1545109712439625","url":null,"abstract":"<p><p>Cerebral toxoplasmosis is common in AIDS patients; however, pneumocystosis of the brain is rarely documented. We report a patient with AIDS hospitalized for brain abscesses. Stereotactic brain biopsy with immunofluorescence staining was positive for Pneumocystis jiroveci. The patient received high doses of cotrimoxazole and had a favorable clinical course.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 3","pages":"169-71"},"PeriodicalIF":0.0,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109712439625","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30533886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mayar Al Mohajer, Michael Lyons, Eileen King, Jesse Pratt, Carl J Fichtenbaum
{"title":"Internal medicine and emergency medicine physicians lack accurate knowledge of current CDC HIV testing recommendations and infrequently offer HIV testing.","authors":"Mayar Al Mohajer, Michael Lyons, Eileen King, Jesse Pratt, Carl J Fichtenbaum","doi":"10.1177/1545109711430165","DOIUrl":"https://doi.org/10.1177/1545109711430165","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the knowledge and attitudes of residents and attendings in emergency medicine (EM) and internal medicine (IM) about HIV.</p><p><strong>Methods: </strong>An electronic anonymous 41-question survey of IM and EM physicians at the University of Cincinnati Academic Health Center.</p><p><strong>Results: </strong>The survey was completed by 232 physicians (71.6%). EM residents were more likely to routinely offer HIV testing compared to IM residents (60.7% vs. 27.8%, P = 0.0009). Overall, there was no difference in offering HIV testing by sex (32% vs. 35.6%) or by residents versus attendings (33.8% vs. 33.3%). Only 70 physicians (30.9%) were aware of current CDC recommendations of HIV screening with attendings more knowledgeable than residents (41.7% vs. 26%, P = 0.017).</p><p><strong>Conclusion: </strong>EM and IM residents and attendings fail to offer HIV testing or assess for HIV transmission risk factors with sufficient frequency. There is also a gap in knowledge of the current CDC recommendations.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 2","pages":"101-8"},"PeriodicalIF":0.0,"publicationDate":"2012-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109711430165","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30462079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A potential drug-herbal interaction between Ginkgo biloba and efavirenz.","authors":"Mark Naccarato, Deborah Yoong, Kevin Gough","doi":"10.1177/1545109711435364","DOIUrl":"https://doi.org/10.1177/1545109711435364","url":null,"abstract":"<p><p>Efavirenz (EFV) is primarily metabolized by cytochrome P450 (CYP) 2B6 and to a lesser extent by CYP3A4. Drugs that significantly inhibit or induce these enzymes would then be expected to increase or lower the levels of EFV potentially resulting in toxicity or therapeutic failure, respectively. The constituents of Ginkgo biloba extract have been demonstrated to induce gene expression of the CYP450 enzymes. We report a case in which a potential drug-herb interaction may have led to virological breakthrough in a patient that was maintained on the same regimen for 10 years. Therefore, a drug-herbal interaction may be expected when these agents are taken concurrently, and we advise clinicians to avoid this combination when possible.</p>","PeriodicalId":86092,"journal":{"name":"Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)","volume":"11 2","pages":"98-100"},"PeriodicalIF":0.0,"publicationDate":"2012-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1545109711435364","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30450310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}